- Trials with a EudraCT protocol (69)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (11)
69 result(s) found for: Sympathetic.
Displaying page 1 of 4.
EudraCT Number: 2010-019997-33 | Sponsor Protocol Number: 2010/03 | Start Date*: 2010-06-02 | ||||||||||||||||
Sponsor Name:Leiden University Medical Center | ||||||||||||||||||
Full Title: Responsiveness to botulinum toxinum type A in complex regional pain syndrome related fixed dystonia | ||||||||||||||||||
Medical condition: CRPS with dystonia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024558-12 | Sponsor Protocol Number: CRPS-1-2011-2014 | Start Date*: 2011-02-17 | |||||||||||
Sponsor Name:Aalto-yliopiston Kylmälaboratorion Aivotutkimusyksikkö | |||||||||||||
Full Title: CRPS-potilaiden aivomuutosten korjaantuminen hoidon myötä | |||||||||||||
Medical condition: Complex regional pain syndrome tyyppi 1 eli CRPS-I -potilaita | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010557-12 | Sponsor Protocol Number: Version1.0/Jan2009 | Start Date*: 2012-03-01 | |||||||||||
Sponsor Name:The Pennine Acute Hospitals NHS Trust | |||||||||||||
Full Title: A Single Blind, Randomised, Cross-over Study to Compare the Efficacy of Lidocaine 5% Plasters(Versatis) versus Pregabalin (Lyrica) in the Treatment of Complex Regional Pain Syndrome, Type 1. | |||||||||||||
Medical condition: Complex regional pain syndrome type 1. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001164-11 | Sponsor Protocol Number: KF7013-03 | Start Date*: 2017-04-24 | ||||||||||||||||
Sponsor Name:Grünenthal GmbH | ||||||||||||||||||
Full Title: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) | ||||||||||||||||||
Medical condition: Complex regional pain syndrome (CRPS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001915-37 | Sponsor Protocol Number: KF7013-01 | Start Date*: 2015-08-28 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: A randomized, double-blind trial investigating the efficacy and safety of intravenous neridronic acid in subjects with complex regional pain syndrome type I (CRPS-I) | |||||||||||||
Medical condition: Complex regional pain syndrome type I (CRPS-I) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007794-23 | Sponsor Protocol Number: PAINLESS | Start Date*: 2009-05-28 | |||||||||||
Sponsor Name:Justus-Liebig-University | |||||||||||||
Full Title: Prospektive, doppelblinde, randomisierte, Plazebo-kontrollierte Cross-over Studie zur Wirkung von intravenösen Immunglobulinen bei komplex-regionalem Schmerzsyndrom Typ I (M. Sudeck) | |||||||||||||
Medical condition: complex-regional pain syndrome type 1 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009334-32 | Sponsor Protocol Number: 07012009 | Start Date*: 2009-12-28 |
Sponsor Name:University medical center Utrecht | ||
Full Title: Effect of Statins on Sympathetic Activity in Hypertensive Patients with Chronic Kidney Disease: a Randomized trial in Hypertensive Patients with Chronic Kidney Disease | ||
Medical condition: atients older than 18 years old with stable chronic kidney disease and hypertension are included in this project. Patients with diabetes mellitus, patients on renal replacement therapy, patients on... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003833-91 | Sponsor Protocol Number: KF7013-02 | Start Date*: 2018-10-04 | ||||||||||||||||
Sponsor Name:Grünenthal GmbH | ||||||||||||||||||
Full Title: Randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) | ||||||||||||||||||
Medical condition: Complex Regional Pain Syndrome (CRPS). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001527-22 | Sponsor Protocol Number: AXS02-301 | Start Date*: 2015-09-25 | |||||||||||
Sponsor Name:Axsome Therapeutics, Inc. | |||||||||||||
Full Title: CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered ... | |||||||||||||
Medical condition: Complex regional pain syndrome (CRPS-I). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004750-21 | Sponsor Protocol Number: TAK-935-2008 | Start Date*: 2019-06-10 | ||||||||||||||||
Sponsor Name:Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda | ||||||||||||||||||
Full Title: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Adult Subjects With Chronic Complex Regional... | ||||||||||||||||||
Medical condition: Complex Regional Pain Syndrome (CRPS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-005557-24 | Sponsor Protocol Number: 69HCL18_0996 | Start Date*: 2021-05-10 | |||||||||||
Sponsor Name:Hospices Civils de Lyon - Direction de la Recherche Clinique et de l'Innovation | |||||||||||||
Full Title: Étude pilote visant à évaluer l’efficacité d’un mélange de kétamine/lidocaïne administré par mésothérapie dans la prise en charge des douleurs neuropathiques du Syndrome Douloureux Régional Complex... | |||||||||||||
Medical condition: Complex regional pain syndrome type I | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004973-29 | Sponsor Protocol Number: CL3-78989-019 | Start Date*: 2014-08-13 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A safety open-label study of Gevokizumab in the treatment of patients with chronic non-infectious Uveitis disease, an eXtension study. The EYEGUARD-X study. | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: chronic non-infectious uveitis | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) IT (Completed) PT (Completed) ES (Completed) AT (Completed) GR (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001610-42 | Sponsor Protocol Number: X052130/CL3-78989-005 | Start Date*: 2013-01-24 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:XOMA (US) LLC | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Non-infectious Intermediate, Posterior, or Pan- Uveitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) PT (Completed) GB (Prematurely Ended) ES (Completed) GR (Prematurely Ended) AT (Completed) PL (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001609-25 | Sponsor Protocol Number: X052131/CL3-78989-006 | Start Date*: 2013-01-02 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:XOMA (US) LLC | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A RandomizEd, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of GevokizUmAb in the TReatment of Subjects with Non-infectious IntermeDiate, Posterior, or Pan- uveitis Currently C... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Non-infectious Intermediate, Posterior, or Pan- Uveitis | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) PT (Completed) IT (Completed) GR (Prematurely Ended) ES (Completed) PL (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003822-80 | Sponsor Protocol Number: 04/035 | Start Date*: 2005-01-12 |
Sponsor Name:The Leeds Teaching Hospitals NHS Trust | ||
Full Title: Modulation of Sympathetic Nerve Activity By Pioglitazone In Type 2 Diabetes Mellitus | ||
Medical condition: Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012449-48 | Sponsor Protocol Number: ALS-8-09-A-101 | Start Date*: 2009-11-09 |
Sponsor Name:Air Liquide Santé International | ||
Full Title: „Sympathetic neural outflow during Xenon anesthesia in humans“ | ||
Medical condition: We would like to frame the thesis, that a general, inhalative Xenon anesthesia (1 MAC) does not effect the sympathetic outflow and the sympathetic baroreflex reagibility under spontaneous breathing... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000411-10 | Sponsor Protocol Number: 4478944789 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||||||||||||
Sponsor Name:BG-Kliniken Bergmannsheil, Dept. of Pain Management | |||||||||||||||||||||||||||||||||
Full Title: Effects of Pregabalin on mechanical hyperalgesia - EPOM | |||||||||||||||||||||||||||||||||
Medical condition: patients with pain for at least 6 months and hyperalgesia with one of the following diagnoses: peripheral nerve lesion, plexus lesion, radicular lesion, spinal lesion, polyneuropathy, postzosteric ... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000394-36 | Sponsor Protocol Number: M17-05-LCZ-ARNI | Start Date*: 2017-12-20 | |||||||||||
Sponsor Name:Hannover Medical School | |||||||||||||
Full Title: Influences of angiotensin-neprilysin inhibition with Sacubitril/Valsartan (ENTRESTO®) on centrally generated sympathetic activity in heart failure patients | |||||||||||||
Medical condition: Chronic heart failure with reduced left ventricular ejection fraction (NYHA II-III) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004460-66 | Sponsor Protocol Number: KARAASS-1 | Start Date*: 2014-04-01 | ||||||||||||||||
Sponsor Name:Jørgen Jeppesen | ||||||||||||||||||
Full Title: Oral potassium supplementation in healthy men - interactions with the renin-angiotensin-aldosterone system and the sympathetic nervous system | ||||||||||||||||||
Medical condition: Blood pressure regulation and hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002202-43 | Sponsor Protocol Number: Empa_MIBG | Start Date*: 2021-04-28 | |||||||||||
Sponsor Name:AOU FEDERICO II | |||||||||||||
Full Title: Effects of empagliflozin on cardiac remodeling and myocardial sympathetic nervous system in diabetic patients affected by chronic heart failure | |||||||||||||
Medical condition: diabetes mellitus and heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
